We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals

213 hedge funds and large institutions have $764M invested in Amphastar Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 71 increasing their positions, 83 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

325% more call options, than puts

Call options by funds: $1.34M | Put options by funds: $316K

67% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 15

3% more funds holding

Funds holding: 207213 (+6)

0.6% less ownership

Funds ownership: 60.9%60.3% (-0.6%)

9% less capital invested

Capital invested by funds: $839M → $764M (-$74.8M)

14% less repeat investments, than reductions

Existing positions increased: 71 | Existing positions reduced: 83

Holders
213
Holders Change
+6
Holders Change %
+2.9%
% of All Funds
3.42%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
71
Reduced
83
Closed
15
Calls
$1.34M
Puts
$316K
Net Calls
+$1.03M
Net Calls Change
-$807K
Name Holding Trade Value Shares
Change
Change in
Stake
Macquarie Group
226
Macquarie Group
Australia
-$13K
SFG
227
Steward Financial Group
Texas
+$29 +1 New
NA
228
NewEdge Advisors
Louisiana
+$319 +11 New